Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma

Development and Validation of a Tumor Mutation Burden–Related Immune Prognostic Model for Lower-Grade Glioma

Tumor mutation burden (TMB) is a useful biomarker to predict prognosis and the efficacy of immune checkpoint inhibitors (ICIs). In this study, we aimed to explore the prognostic value of TMB and the potential association between TMB and immune infiltration in lower-grade gliomas (LGGs). Somatic muta...

Full description

Bibliographic Details
Main Authors: Wen Yin, Xingjun Jiang, Jun Tan, Zhaoqi Xin, Quanwei Zhou, Chaohong Zhan, Xianyong Fu, Zhaoping Wu, Youwei Guo, Zhipeng Jiang, Caiping Ren, Guihua Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
tumor mutation burden (TMB)
lower-grade glioma (LGG)
immune infiltration
immune-related risk score system
nomogram
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01409/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01409/full

Similar Items